Shares of agilon health, inc. (AGL) plummeted 5.12% during intraday trading on Friday, as investors reacted to a significant downgrade from a major financial institution. The healthcare company's stock has been under pressure following a bearish move by analysts.

The primary catalyst for the sharp decline appears to be Deutsche Bank's decision to cut its price target on Agilon Health by half, from $2 to $1. This drastic reduction in the expected value of the stock has likely shaken investor confidence, prompting a sell-off in the market.

Despite the negative sentiment from Deutsche Bank, it's worth noting that the overall analyst consensus on Agilon Health remains mixed. According to FactSet, the stock currently has an average rating of "hold" among analysts, with a mean price target of $4.33. This suggests that while some institutions are becoming more bearish on the stock, others still see potential upside, albeit with a cautious outlook.